Swedish renewable energy developer Eolus has reached an agreement with a privately held US renewable energy producer to sell ...
The US Food and Drug Administration (FDA) has granted orphan drug designation (ODD) to NMD Pharma’s oral lead development programme, NMD670, designed to treat Charcot-Marie-Tooth disease (CMT). A ...
A GlobalData survey shows 82% of Gen Z and 84% of Millennials thought ingredients helping relaxation or boosting mood were ...
Based on the data, China’s domestic market saw its second consecutive month of acceleration in November.
7h
We recently compiled a list of the 10 Best Diabetes Stocks To Buy Under $10. In this article, we are going to take a look at ...
Consumer hesitation around taste remains a main challenge to successfully marketing alternative food and drink products, says GlobalData.
We recently compiled a list of the 10 Best Diabetes Stocks To Buy Under $10. In this article, we are going to take a look at ...
About 422 million people worldwide have diabetes, according to the WHO, and most of them live in low- or middle-income ...
The heart failure market is expected to grow at a 9.6% CAGR from $13.5bn in 2022 to $33.7bn in 2032 in the 7MM.
MET-3 is under development for the treatment of hypertriglyceridemia. It comprises live microbiota that normally reside in the human gut of a healthy individual. It is administered through oral route ...
President-elect Donald Trump’s threat to eliminate tax credits for electric vehicles likely gave plug-in cars a much-needed boost after a disappointing year, part of a broader surge in auto sales ...
As inflation continues to squeeze household budgets across the Asia-Pacific (APAC) region, consumers are increasingly turning ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback